- SEC Releases
- Press Releases
- Corporate Governance
- Investors Contact
SEC RELEASES
LATEST ANNOUNCEMENTS
February 11, 2019
To Our Shareholders
The last year was a critical year in which we laid the foundations for the sustainable success for our Company. We defined our strategy carefully and consolidated our positioning as a company which undertakes the research and development of fully validated medical products and pharmaceuticals based on cannabis.
December 31, 2018
FORM 10-K
The following documents (or parts thereof) are incorporated by reference into the following parts of this Form 10-K: Certain information required in Part
III of this Annual Report on Form 10-K is incorporated from our definitive proxy statement for the 2019 annual meeting of stockholders to be filed pursuant to Regulation 14A with the Securities and Exchange Commission within 120 days of our fiscal year ended December 31, 2018.
